MoneyWorks4Me

Jenburkt Pharmaceuticals informs about compliance certificate

24 Oct 2017 Evaluate

Jenburkt Pharmaceuticals has informed about a certificate for the compliance under Regulation 40(9) regarding issuance of Share Certificates within the stipulated time for the period from 1st April, 2017 to 30th September, 2017, as received from Nilesh G. Shah, Practicing Company Secretary.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..